...
首页> 外文期刊>Current Drug Metabolism >Permeability – In Vitro Assays for Assessing Drug Transporter Activity
【24h】

Permeability – In Vitro Assays for Assessing Drug Transporter Activity

机译:渗透性–评估药物转运蛋白活性的体外测定

获取原文
获取原文并翻译 | 示例
           

摘要

The accumulating evidence has revealed that drug transporters have essential roles in the delivery and excretory processes of drugs and their metabolites. Inhibition or induction of drug transporters can affect pharmacokinetic properties and therapeutic efficacy of a drug. Thus, the characterization of drug-transporter interactions becomes important for the selection of compounds to avoid transporter associated absorption, distribution, metabolism, excretion and toxicity (ADME/Tox) issues. Additionally, the potential use of absorptive transporters for drug delivery has been recognized for drug design. In vitro and in vivo approaches have been developed for studying the transporter activities. In vitro assays can rapidly provide the information for identifying interaction of a compound and a particular transporter and have proved to be amenable to high throughput approaches. Therefore, the studies are conducted in early drug discovery. In this article, in vitro methods are reviewed, including cell free and cell-based assays. Their applications, limitations and impact on drug discovery are discussed.
机译:越来越多的证据表明,药物转运蛋白在药物及其代谢物的传递和排泄过程中起着至关重要的作用。抑制或诱导药物转运蛋白会影响药物的药代动力学性质和治疗功效。因此,药物-转运蛋白相互作用的表征对于选择化合物以避免与转运蛋白相关的吸收,分布,代谢,排泄和毒性(ADME / Tox)问题变得重要。另外,吸收性转运蛋白在药物递送中的潜在用途已被公认用于药物设计。已经开发了用于研究转运蛋白活性的体外和体内方法。体外测定可以快速提供用于鉴定化合物与特定转运蛋白相互作用的信息,并已证明适用于高通量方法。因此,这些研究是在早期药物发现中进行的。本文对体外方法进行了综述,包括无细胞和基于细胞的测定。讨论了它们的应用,局限性以及对药物发现的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号